Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk
BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7167.1202 (Published 31 October 1998) Cite this as: BMJ 1998;317:1202- Ann Louise Kinmonth, professora,
- Alison Woodcock, senior research fellowa,
- Simon Griffin, Wellcome training fellowa,
- Nicki Spiegal, management consultantb,
- Michael J Campbell, senior lecturer in medical statisticsc,
- The Diabetes Care from Diagnosis Research Team
- Primary Medical Care Group (Aldermoor Health Centre), Faculty of Health, Medicine and Biological Sciences, University of Southampton, Southampton SO16 5ST
- Willowbank, Spicers, Ashdell Park, Alton, Hampshire GU34 2SJ
- Medical Statistics and Computing, Faculty of Health Medicine and Biological Sciences, University of Southampton
- Correspondence to: Professor Ann Louise Kinmonth, General Practice and Primary Care Research Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 2SR
- Accepted 14 August 1998
abstract
Objective To assess the effect of additional training of practice nurses and general practitioners in patient centred care on the lifestyle and psychological and physiological status of patients with newly diagnosed type 2 diabetes.
Design Pragmatic parallel group design, with randomisation between practice teams to routine care (comparison group) or routine care plus additional training (intervention group); analysis at one year, allowing for practice effects and stratifiers; self reporting by patients on communication with practitioners, satisfaction with treatment, style of care, and lifestyle.
Setting 41 practices (21 in intervention group, 20 in comparison group) in a health region in southern England.
Subjects 250/360 patients (aged 30-70 years) diagnosed with type 2 diabetes and completing follow up at one year (142 in intervention group, 108 in comparison group).
Intervention 1.5 days' group training for the doctors and nurses—introducing evidence for and skills of patient centred care and a patient held booklet encouraging questions.
Main outcome measures Quality of life, wellbeing, haemoglobin A1c and lipid concentrations, blood pressure, body mass index (kg/m2).
Results Compared with patients in the C group, those in the intervention group reported better communication with the doctors (odds ratio 2.8; 95% confidence interval 1.8 to 4.3) and greater treatment satisfaction (1.6;1.1 to 2.5) and wellbeing (difference in means (d) 2.8; 0.4 to 5.2). However, their body mass index was significantly higher (d=2.0; 0.3 to 3.8), as were triglyceride concentrations (d=0.4 mmol/l; 0.07 to 0.73 mmol/l), whereas knowledge scores were lower −2.74;−0.23 to −5.25. Differences in lifestyle and glycaemic control were not significant.
Conclusions The findings suggest greater attention to the consultation process than to preventive care among trained practitioners; those committed to achieving the benefits of patient centred consulting should not lose the focus on disease management.
Key messages
A training programme in patient centred care for practitioners led to patients with newly diagnosed diabetes reporting better communication with doctors, greater wellbeing, and greater treatment satisfaction at one year, without loss of glycaemic control
Knowledge scores were lower and weight and other cardiovascular risk factors higher among patients attending trained practice teams
Trained practitioners may have found it difficult to integrate attention to wellbeing with management of disease risk
Professionals using patient centred consulting should not lose the focus on disease
Introduction
It is well understood that doctors and nurses do not deal with diseases alone but with individuals who are ill or concerned about their health.1 A “patient centred” clinical method recognises this and specifically teaches practitioners ways of integrating the patients' perspectives with the consultation. 2 3
When this integrated approach is achieved processes and outcomes of care can improve.4Outcomes studied include satisfaction,5 anxiety, 6 7 adherence to treatment,7symptom resolution,4 and physiological and functional status.8Most studies have been in secondary care and have integrated patients' concerns by direct coaching of patients. 5 8 A Medline search (1966-96) identified no trials of increased patient involvement in primary care through training programmes for practitioners that measured both disease and patient centred outcomes. We evaluated a practical programme for primary care practitioners to use with patients with newly diagnosed type 2 diabetes.
The hypothesis was that additional training for practitioners in a patient centred approach would lead to better communication between patient and practitioner, healthier lifestyle choices, andimproved clinical, social, and psychological outcomes among patients during their first year with diabetes, compared with routine care.
Methods
Assignment and masking
The hypothesis was tested in a pragmatic trial with initial stratified random allocation of practices by computer to two groups— one trained to give patient centred care (intervention group) and a comparison group trained to give routine care (fig 1). Practice teams agreed to randomisation to “different approaches to early diabetes care.” Assessment of patients was by research nurses, also unaware of the groups. The trial was conducted within a wider study of the incidence and presentation of type 2 diabetes.
Protocol
Setting
The study comprised 41 practices (mid-study list size 455 566) in Wessex, a health region in southern England; 21 practices were randomised to the intervention group and 20 to the comparison group.
Recruitment of practice teams
Inclusion criteria were:≥4 medical partners; list size >7000; a diabetes register with >1% of practice population; and a diabetes service registered with the health authority. In all, 245/467 (52%) of all practice teams were eligible. Forty three practice teams were recruited.9Immediately after randomisation, one practice in each group dropped out because of unexpected commitments. Results are presented for the 41 practice teams who began recruiting patients. Teams in the intervention practices had a total of 23 doctors and 32 nurses; teams in the comparison practices had 20 doctors and 32 nurses. At least one doctor and one nurse from each intervention practice received training.
Recruitment of patients
For 12 months nurses reported all new cases of diabetes, as defined by the doctor, to the trial office. Willing patients aged 30-70 years were included in the trial. Patients were excluded if they were private patients, housebound, mentally ill, had severe learning difficulties, or were subsequently found to have been diagnosed previously with, or not to have, diabetes, or were found to have type 1 diabetes. Patients signed two consent forms—one near the time of diagnosis allowing the practice to release anonymised clinical information, and the second later on, agreeing to the collection of clinical and psychological data by questionnaire.
Approaches to care
The two approaches to care were developed in collaboration with practice teams and patients. Care was based on national guidelines 1011and materials for patients,12 with (intervention group) or without (comparison group) additional training in patient centred care. Nurses in the intervention group were offered half a day's training to review the evidence for patient centred consulting and a further full day in which to practise the skills learned, with an experienced facilitator throughout. Doctors received only the first half day's training. Skills included active listening and negotiation of behavioural change. Materials produced for the intervention group included a booklet for patients, Diabetes in your Hands (which encouraged patients to ask questions), an optional leaflet for patients encouraging discussion of complications and concerns, and a booklet for practitioners describing approaches to behaviour change.
During two further half day support sessions with the facilitator, nurses reviewed their skills and attitudes in the light of experience (fig 1). Nurses in the comparison group were offered similar support sessions focusing on use of guidelines and materials.10–12 The training programme and its evaluation by practitioners has been described.9
Measures
Baseline and one year clinical data, including details of prescriptions, were provided by nurses from clinical notes; research nurses and project staff collected one year data from patients and practitioners, by questionnaire and home interviews, and measures of height, weight, and blood pressure. The baseline measures for practices, practitioners, and patients are summarised in the table: there were no significant differences between groups for important baseline variables at these 3 levels; practitioners reported slightly greater confidence in managing diabetes than the average person in their profession.13 A minority of patients attended hospital for diabetes education in both groups.
Processes measured comprised use of skills and materials; patients' ratings of communication with doctors and nurses (covering the ability to tell the doctor or nurse personal or troubling things and feeling understood); satisfaction with treatment14 and style of care; agreement between patient and practitioner on main concerns over the previous year; perceived control of diabetes14; and patient knowledge (covering critical areas of self care—such as diet and avoidance of hypoglycaemia and complications—and monitoring skills).
Principal outcomes included lifestyle, blood glucose control, and psychological status. Lifestyle was assessed by self report measures.15–17
Clinical status was determined by percentage of glycated haemoglobin (haemoglobin A1cion exchange chromatography; reference range 4.68-6.80%), total plasma cholesterol concentration(cholesterol oxidase), plasma triglyceride concentration (glycerol phosphate-oxidase), height (Harpenden pocket stadiometer), weight (Seca 835 electronic scales), systolic and diastolic blood pressure (Omron electronic), and ratio of urinary albumin and creatinine (immunoturbidometric assay and modified Jaffé reaction). Smoking status was reported to research nurses and confirmed by determining urinary cotinine concentration (commercial immunoassay kit).
We used several measures of functional and psychological status (see fig 4). The audit of diabetes dependent quality of life (ADDQoL) measures the perceived impact of diabetes on different areas of patients' lives, weighted by importance to the individual.14 The wellbeing questionnaire14excludes somatic symptoms, whichcan overlap with symptoms of uncontrolled diabetes.
Some of the above measures were developed for the study, others were modified from published sources. Details are available from the authors.
Validation and quality assurance
Postal questionnaires were piloted (report to the British Diabetic Association, 1996). Research nurses were trained in interviewing using videotaping. Measurement errors in height, weight, and blood pressure between and within observers were assessed before and after the study and were small. Patients were allocated to research nurses in equal proportions across the two groups. Biochemical tests were carried out in a single laboratory. Ethical approval was obtained in eight districts of the region.
Statistical analysis and sample size
With 80% power and 95% confidence, 100 patients in each group allowed detection of 20% difference in dietary change16 and 1% (SD 2.22%) difference in hae oglobin A1c.8Practice numbers were based on published incidence estimates.18Patients' results were corrected for clustering at practice level (STATACORP 1997) and adjusted for stratifiers (fig 1 ). Intraclass correlation coefficients were 0.045 for body mass index and 0.047 for haemoglobin A1c. Analysis was by intention to treat. Multiple or logistic regression was used as appropriate. Adjusted odds ratios on scales dichotomised at the median, or adjusted differences between means are presented.
Results
Participant flow
From April 1994 to June 1995 the 41 practice teams diagnosed type 2 diabetes in 522 patients, of whom 360 (range 1-22 per practice) were aged 30-70 years and therefore eligible for inclusion. In all, 250 (69.4%) of the patients with type 2 diabetes completed the study (142 in the intervention group, 108 in the comparison group)—85% of the patients who were not dead and had not moved away. The non-respondents were equally distributed across both groups; sex distribution was similar among the respondents and non-respondents, but non-respondents were on average 2.5 years younger (P=0.04).
Application of intervention
All trained nurses who responded (28/32) used the booklet Diabetes in Your Hands, and at the end of the study 105 (74%) patients in the intervention group recognised it, compared with two (2%) in the comparison group. Only seven nurses gave the leaflet on complications and concerns to all patients, and 35 (25%) patients in the intervention group recalled having seen it. Similar proportions of patients in both groups had seen the British Diabetic Association's publications (79 (56%) in the intervention group, 68 (63%) in the comparison group)).12All responding trained nurses (28/32) and doctors (19/23) reported using patient centred consulting, with 17 nurses and 15 doctors reporting extensive use (4-5 on a 5 point scale). Nurses reported considerable use of listening skills, open questions, and affirming comments but less use of aids to behaviour change. Further details are reported separately.19
Analysis
Process of care
Results for patients' ratings of the process of care are shown in figure 2.Communication and satisfaction were rated highly by both groups. Patients in the intervention group were significantly more likely than those in the comparison group to report excellent communication with doctors and great satisfaction with treatment. Agreement between patients and practitioners on main concerns discussed over the year and perceived personal control were similar in both groups. Knowledge scores were significantly lower in the intervention group than the comparison group, and differences were confined to the patients who had been prescribed hypoglycaemic drug treatment. Knowledge of diet was similar in both groups, as was belief that poor control of diabetes may lead to complications (133 (94%) patients in the intervention group, 106 (98%) in the comparison group) and that they would have diabetes for the rest of their lives (124 (88%)and 94 (87%) patients respectively).
Outcomes
Diet and exercise scores were similar in both groups. Both groups reported high intakes of fibre and unsaturated fat and low intake of total fat.15 Similar proportions in both groups reported change towards a healthy diet.16Mean exercise scores were 26.2 in the intervention group and 29.7 in the comparison group (score of 21 represents 15 minutes' light exercise daily, 35 represents 15 minutes' moderate exercise daily).17
Fifty per cent (66/133) of the patients in the intervention group and 46% (46/99) in the comparison group were prescribed hypoglycaemic agents; 47% (62/133) and 40% (40/99) respectively were prescribed sulphonylureas, and 11% (15/133) and 15% (15/99) respectively were prescribed metformin. Two patients were prescribed insulin and 20 both sulphonylureas and metformin.The results of clinical measures at one year are shown in figure 3. Mean haemoglobin A1c concentrations were close to the normal range, with those in the intervention group 0.24% lower than those in the comparison group (when adjusted, not significant). Differences were no larger among patients in whom diabetes was diagnosed later in the study. Mean body mass index (weight(kg)/(height(m)2)) was high (30.5) and 2.04 higher in the intervention group than the comparison group. Weight loss measured over the year by practice nurses was 0.75 kg in the intervention group (n=130) and 1.74 kg in the comparison group (n=93) (adjusted difference 0.60 kg; P=0.41). Adjustment for prescribed hypoglycaemic agents by inclusion in the regression analysis did not affect these findings. However, stratification by prescribed hypoglycaemic drugs increased the group differences. Among the patients prescribed such drugs, the difference in haemoglobin A1c concentrations between the two groups was −0.31% (95% confidence interval −0.76% to 0.13%), and body mass index was 4.99 higher in the intervention group (3.46 to 6.53). Among the patients who did not receive hypoglycaemic agents, the difference in body mass index between the two group was −0.37 −3.45 to 2.72). Blood triglyceride concentrations were higher in the intervention group than the comparison group, with a similar but non-significant trend for blood pressure. The two groups did not differ in total blood cholesterol concentration, microalbuminuria, orsmoking status.
Functional and psychological status favoured the intervention group, and wellbeing scores were significantly higher in the intervention group than the comparison group (fig 4).
Discussion>
This is the first randomised trial in primary care to show that training in patient centred care, with a focus mainly on nurses, can significantly improve communication, wellbeing, and satisfaction among patients with newly diagnosed diabetes, without loss of glycaemic control.
Methodology
The trial employed rigorous methodology, conforming both to the CONSORT statement20and to many of the guidelines for participatory research,21and was completed by 85% of eligible patients.
Our analysis was conservative, allowing for clustering at practice level. In addition, concealment of the hypothesis from practitioners meant that committed patient centred practitioners might have been randomised to the comparison group and “disease centred” practitioners randomised to receive patient centred training. Despite this conservatism, the pragmatic design still showed important effects on process and patient outcomes, whichshould be generalisable to the increasing numberof larger practices providing organised diabetes care.
However, we had hypothesised that the intervention would lead to improved agreement between patients and practitioners on main concerns,22greater perceived control of diabetes,14 healthier lifestyle, and greater knowledge of self care23—all aspects previously associated with improved health status and possibly the result of greater adherence to treatment. 7 24 We did not find this, but we do not know whether this is because of the limitations of our measures or lack of a real effect. In particular, measurement of diet and exercise by self report has considerable limitations25 and may reflect knowledge rather than behaviour, as suggested by the discrepancies here between reported diet and observed weight.
Interpretation
The differences in knowledge scores are consistent with a less systematic approach to teaching among practitioners in the intervention group. They may have dealt with patients' immediate concerns, rather than integrating them with management of disease risk. Certainly, practitioners in the intervention group used the booklet Diabetes in your Hands (which encourages patients to ask questions) much more than the accompanying leaflet identifying possible diabetic complications. Nurses also reported greater use of listening skills than negotiation of behavioural change.19Nor did we find evidence that management improved with experience:haemoglobin A1c concentrations among the patients in whom type 2 diabetes was diagnosed later in the study were no lower at one year. Use of listening skills by practitioners without negotiation of behavioural change could result in higher cardiovascular risk despite improved satisfaction and wellbeing.
Another explanation, however, also deserves consideration. Weight was higher in the intervention group than the comparison group, and blood pressure differences followed weight differences. These differences were confined to patients prescribed hypoglycaemic agents and were not accounted for by small differences in prescribing rates between the two groups.
Evidence is increasing that involving patients more in consultations can increase adherence to treatment, 7 24 and after type 2 diabetes is diagnosed weight increases more with more intensive treatment.26It would be ironic if this mechanism contributed to the higher cardiovascular risk in the intervention group and underlines the therapeutic dilemma in type 2 diabetes of treating both hyperglycaemia and cardiovascular risk effectively.
In retrospect, our study, based on effect sizes among patients with established diabetes,8 was underpowered to detect the small differences in blood glucose concentrations achievable one year after diagnosis.26 Despite near normal concentrations achieved in both groups, however, the results are compatible with clinically important differences in haemoglobin A1c favouring the intervention group.Longer, larger studies are still needed to test the effect of patient centred care on diabetes control after diagnosis. It remains unclear whether the risks of increasing body weight and associated adverse cardiovascular risk will outweigh any benefits of improved communication, wellbeing, treatment satisfaction, or even improved glycaemic control over time. The results of the UK prospective diabetes study provide reassurance on these points,27 but further detailed research on the psychosocial correlates of survival and health status is needed. 2728 Results of current trials and other studies of the psychosocial correlates of survival and health status should inform this question. In the meantime, clinical method must balance listening and directing and address not only patients' wellbeing but also the threat to it of adverse risk profiles.
Conclusion
Despite limitations, this study shows the power of the consultation to affect patients' health and wellbeing. Professionals committed to achieving the benefits of patient centred consulting should take care not to lose the focus on disease while paying attention to the unique experience of illness of each patient.
Acknowledgments
The other members of the Diabetes Care from Diagnosis Research Team are Helen Burgess, Candy McCabe, Valerie Davill, Robert Peveler, and David Rowe (University of Southampton); and Clare Bradley (Royal Holloway College, University of London). We thank the staff of the department of chemical pathology at Southampton General Hospital, Sarah Duggleby and Phillipa Clarke at the MRC Environmental Epidemiology Unit, and Bruce Thomas and Colin Coles at the University of Bournemouth for help in nurse training and the patients, nurses, and general practitioners in the collaborating practices. The collaborating practices were: Abbotsbury Road Practice, Weymouth; Adelaide Medical Centre, Andover; Aldermoor Health Centre, Southampton; Alma Road Surgery, Southampton; Gosport Health Centre, Gosport; Baffins Road Surgery, Southampton; Bitterne Surgery, Southampton; Charlton Hill Surgery, Andover; Cosham Health Centre, Cosham; New Milton Health Centre, New Milton; Drayton Surgery, Drayton; Endless Street Surgery, Salisbury; Fratton Road Practice, Portsmouth; Friarsgate Practice, Winchester; Gable House Surgery, Malmsbury; Hadleigh House Practice, Broadstone; Hartley Wintney Surgery and the Surgery Hook, Hatch Warren; South Ham Surgery, Basingstoke; Hathaway Surgery, Chippenham; Havant Health Centre Suite A, Havant; Health Centre, Alton; Holmwood Health Centre, Tadley; Lovemead Group Practice, Trowbridge; Marlborough Surgery, Marlborough; Nightingale Surgery, Romsey; Old School House Practice, Gillingham; Priory Road Surgery, Swindon; Quarter Jack Surgery, Wimborne; Ramsbury Surgery, Ramsbury; Richmond Surgery, Fleet; Rowden Surgery, Chippenham; Shirley Avenue and Cheviot Road Surgeries, Southampton; Southlea Surgery, Aldershot; St Clement's Partnership, Winchester; St Chad's Surgery, Midsomer Norton; St Andrew's Surgery, Eastleigh; St Mary's Surgery, Andover; Stockbridge Practice, Stockbridge; The Surgery, Stubbington; The Surgery, Fleet; West End Surgery, Southampton; Westbury Group Practice, Westbury; Westrop Surgery, Highworth; White House Surgery, Weston; Wisteria Surgery, Lymington.
Contributors: ALK developed the original research question and wrote the protocol with AW and MJC and NS. AW led the work on the overall project management, quality assurance, psychological measures, and analysis; MJC led the work on power calculations and analysis; and NS led the training programme. SG took responsibility for the biochemical and physiological measures, quality assurance, and analysis. Helen Burgess was the research secretary; Candy McCabe and Valerie Davill were the research nurses; Robert Peveler was consultant on measures and design; David Rowe was consultant on biochemistry; Claire Bradley was consultant on psychometrics. Staff at the collaborating practices provided clinical data. All the authors participated in the interpretation of the data and writing the paper. ALK will act as guarantor.
Footnotes
-
Funding The study was funded by grants from the Medical Research Council; the South and West region's research and development committee; and the British Diabetic Association. SG received a Wellcome health services research training fellowship. Novo Nordisk supplied the booklets for patients.
-
Conflict of interest None.